当前位置:首页 - 行情中心 - 天目药业(600671) - 财务分析 - 现金流量表

天目药业

(600671)

  

流通市值:27.00亿  总市值:27.00亿
流通股本:1.22亿   总股本:1.22亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金137,547,04539,906,343234,985,355.88137,811,585.19
  收到的税费返还--25,081.0925,081.09
  收到其他与经营活动有关的现金6,361,221.122,525,846.0222,224,324.7216,321,184.82
  经营活动现金流入小计143,908,266.1242,432,189.02257,234,761.69154,157,851.1
  购买商品、接受劳务支付的现金70,053,355.7134,340,825.27148,909,690.64105,825,661.33
  支付给职工以及为职工支付的现金22,816,038.8511,498,161.2942,761,805.2731,625,825.8
  支付的各项税费11,686,366.555,729,674.6624,383,766.0222,524,848.41
  支付其他与经营活动有关的现金15,065,884.0810,293,040.9329,388,350.5225,012,604.36
  经营活动现金流出小计119,621,645.1961,861,702.15245,443,612.45184,988,939.9
  经营活动产生的现金流量净额24,286,620.93-19,429,513.1311,791,149.24-30,831,088.8
二、投资活动产生的现金流量:
  取得投资收益收到的现金--3,993.353,993.35
  处置固定资产、无形资产和其他长期资产收回的现金净额--22,76822,768
  收到的其他与投资活动有关的现金--3,500,0013,500,001
  投资活动现金流入的平衡项目--00
  投资活动现金流入小计--3,526,762.353,526,762.35
  购建固定资产、无形资产和其他长期资产支付的现金7,583,8173,564,722.0631,176,853.4426,663,454.66
  支付其他与投资活动有关的现金--3,500,0013,500,001
  投资活动现金流出小计7,583,8173,564,722.0634,676,854.4430,163,455.66
  投资活动产生的现金流量净额-7,583,817-3,564,722.06-31,150,092.09-26,636,693.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,770,0001,770,000
  其中:子公司吸收少数股东投资收到的现金---1,770,000
  取得借款收到的现金135,733,973.65102,353,973.65162,136,300118,752,800
  筹资活动现金流入小计135,733,973.65102,353,973.65163,906,300120,522,800
  偿还债务支付的现金108,089,15667,547,956144,727,14089,280,000
  分配股利、利润或偿付利息支付的现金3,129,176.21,560,945.596,497,576.744,725,879.46
  支付其他与筹资活动有关的现金5,024,724.342,292,773.2514,509,984.0910,414,637.85
  筹资活动现金流出小计116,243,056.5471,401,674.84165,734,700.83104,420,517.31
  筹资活动产生的现金流量净额19,490,917.1130,952,298.81-1,828,400.8316,102,282.69
五、现金及现金等价物净增加额36,193,721.047,958,063.62-21,187,343.68-41,365,499.42
  加:期初现金及现金等价物余额26,276,647.7926,276,647.7947,463,991.4747,463,991.47
  期末现金及现金等价物余额62,470,368.8334,234,711.4126,276,647.796,098,492.05
补充资料:
  净利润4,941,350.57-7,202,945.17-
  资产减值准备60,200.18-1,657,052.82-
  固定资产和投资性房地产折旧7,197,546.98-14,301,112.85-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧7,197,546.98-14,301,112.85-
  无形资产摊销83,059.5-162,343.23-
  长期待摊费用摊销1,056,759.1-12,547,863.05-
  处置固定资产、无形资产和其他长期资产的损失6,396.08-11,714.52-
  固定资产报废损失220.51--241,401.25-
  财务费用3,376,624.56-7,198,209.47-
  投资损失5,590.28-1,708,564.94-
  递延所得税-212,410.11--913,929.07-
  其中:递延所得税资产减少1,099,478.02--2,728,045.01-
    递延所得税负债增加-1,311,888.13-1,814,115.94-
  存货的减少134,145.52-13,138,461.14-
  经营性应收项目的减少21,015,219.17--50,116,344.22-
  经营性应付项目的增加-19,587,375.95--7,135,831.09-
  融资租入固定资产--20,922,923.65-
  现金的期末余额62,470,368.83-26,276,647.79-
  减:现金的期初余额26,276,647.79-47,463,991.47-
  现金及现金等价物的净增加额36,193,721.04--21,187,343.68-
公告日期2026-08-282026-04-302026-04-182025-10-29
审计意见(境内)标准无保留意见
TOP↑